Aripiprazole versus ziprasidone for schizophrenia
Cochrane Database of Systematic Reviews2017
Citations Over Time
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.
Related Papers
- → Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats(2008)29 cited
- → A 12‐month follow‐up study of treating overweight schizophrenic patients with aripiprazole(2008)15 cited
- The Clinical Research of Aripiprazole Combined with Ziprasidone in the Treatment of Elderly Schizophrenia(2014)
- Effects of Ziprasidone and Aripiprazole on serum prolactin and body weight(2013)
- Evaluation of Ziprasidone and Aripiprazole for schizophrenia and adverse reactions(2009)